ACTON, Mass., May 08, 2018 -- Psychemedics Corporation (NASDAQ:PMD), the world's largest provider of hair analysis drug testing, today announced that James Abely has been promoted to the position of Vice President and General Counsel.
In this important role, Jim is responsible for directing and managing all of the company's legal activities, including working closely with the company's clients, and reports directly to the company's CEO. Jim joined Psychemedics in June 2016 as Associate General Counsel, after practicing law for 6 years with the Boston firm of Goodwin Procter LLP, following his graduation from the University of Virginia School of Law. Jim was later promoted to General Counsel.
In making the announcement, Raymond C. Kubacki, Chairman and CEO of Psychemedics, stated "Jim has been an outstanding addition to our team at Psychemedics. In heading up this important area in our company for the past two years, Jim has worked diligently in numerous legal matters and has clearly demonstrated his ability and strong work ethic. He has won the complete confidence of the other members of our management team, as well as our clients. Besides providing our clients with the most vigorous drug test available and outstanding client service, we also extensively support our clients on any legal challenge. We not only provide a litigation packet and expert testimony, but also legal assistance for our clients' legal team to come up to speed quickly. That's why this is such an important role in our company."
Contact:
Raymond C. Kubacki
Chairman, President & CEO
(978) 206-8220
[email protected]
Psychemedics Corporation is the world’s largest provider of hair testing for the detection of drugs of abuse. The Company’s patented process is used by thousands of U.S. and international clients, including over 10% of the Fortune 500 companies, for pre-employment and random drug testing. Major police departments, Federal Reserve Banks, schools, and other public entities also rely on our unique patented drug testing process. We strongly believe our drug testing method to be superior to any other product currently in use, including traditional urine testing and other hair testing methods.
The Psychemedics web site is www.psychemedics.com


SK Hynix’s $28 Billion U.S. Share Sale Draws Massive Demand Amid AI Chip Boom
Telenor to Buy Controlling Stake in Bahnhof in $630 Million Broadband Deal
SpaceX Stock Draws Bullish Wall Street Coverage Ahead of Nasdaq-100 Inclusion
Japan Regional Bank Stocks Drop After Zentoshin Bankruptcy Sparks Credit Risk Concerns
Netflix, Disney, YouTube Eye FIFA World Cup TV Rights in Multi-Billion Dollar Battle
SK Hynix’s $28B U.S. IPO Draws Strong Demand as AI Chip Boom Fuels Investor Interest
Zhipu AI Stock Jumps on Report of Custom AI Chip Development Plans
Nvidia Invests $500M in Firmus Technologies Ahead of Planned ASX IPO
Wolfspeed Sues Navitas Over GaN and SiC Patent Infringement
Barclays Downgrades Siemens Energy as Valuation Seen Near Peak
BHP Faces Port Hedland Strike Threat as Iron Ore Export Risks Grow
Chinese Chip Stocks Jump as Apple Reportedly Tests CXMT Memory Chips for China Devices
Apple Tests China's CXMT Memory Chips as DRAM Maker Gains Global Market Share
OpenAI GPT-5.6 Set for Wider Release After U.S. Commerce Approval, Report Says
Fast Retailing Raises Full-Year Forecast After Uniqlo Owner Beats Q3 Profit Estimates
Bain Capital Exits Kioxia After AI-Fueled Valuation Surge 



